Similar Papers

Paper Title
Journal
Date
Author
British Society for Haematology guidelines for the management of adult myelodysplastic syndromes.
Sally B Killick ... Jonathan Kell
British Journal of Haematology | VOL. 194
Sally B Killick, et. al.Sally B Killick ... Jonathan Kell
27 Jun 2021
A Systematic Literature Review on the Burden of Illness in Lower-Risk Transfusion-Dependent Myelodysplastic Syndromes
Sohan Deshpande ... Esther Natalie Oliva
Blood | VOL. 134
Sohan Deshpande, et. al.Sohan Deshpande ... Esther Natalie Oliva
13 Nov 2019
The Commands Trial: A Phase 3 Study of the Efficacy and Safety of Luspatercept Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low-, Low-, or Intermediate-Risk MDS in Erythropoiesis Stimulating Agent-Naive Patients Who Require RBC Transfusions
Matteo Della Porta ... Pierre Fenaux
Blood | VOL. 136
Matteo Della Porta, et. al.Matteo Della Porta ... Pierre Fenaux
05 Nov 2020
Clinical benefit of luspatercept treatment (tx) in transfusion-dependent (TD), erythropoiesis-stimulating agent (ESA)–naive patients (pts) with very low-, low- or intermediate-risk myelodysplastic syndromes (MDS) in the COMMANDS trial.
Amer Methqal Zeidan ... Matteo Giovanni Della Porta
Journal of Clinical Oncology | VOL. 42
Amer Methqal Zeidan, et. al.Amer Methqal Zeidan ... Matteo Giovanni Della Porta
01 Jun 2024
View more papers

More From: Blood research

Paper Title
Journal
Date
Author
Correction: Strategies for integrating ChatGPT and generative AI into clinical studies.
Jeong-Moo Lee
Blood research | VOL. 60
Jeong-Moo LeeJeong-Moo Lee
21 Jan 2025
Post-transplant cyclophosphamide plus anti-thymocyte globulin decreased serum IL-6 levels when compared with post-transplant cyclophosphamide alone after haploidentical hematopoietic stem cell transplantation
Jeong Suk Koh ... Ik-Chan Song
Blood Research | VOL. 60
Jeong Suk Koh, et. al.Jeong Suk Koh ... Ik-Chan Song
15 Jan 2025
Efficacy of bortezomib combined with Hyper-CVAD in adults with relapsed acute lymphoblastic leukemia or positive measurable residual disease; effect of bortezomib in leukemia
Christian Omar Ramos Peñafiel ... Adolfo Martínez Tovar
Blood Research | VOL. 60
Christian Omar Ramos Peñafiel, et. al.Christian Omar Ramos Peñafiel ... Adolfo Martínez Tovar
14 Jan 2025
Correction: Acute myeloid leukemia and myelodysplastic neoplasms: clinical implications of myelodysplasia‑related genes mutations and TP53 aberrations.
Hyunwoo Kim ... Won Sik Lee
Blood research | VOL. 60
Hyunwoo Kim, et. al.Hyunwoo Kim ... Won Sik Lee
13 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.